GlassScriptPhysician profile
Norman Minars
NPI 1558357491
$1,385.00
in general payments reported to CMS, 2019-2025
17 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $135 · 2021: $244 · 2022: $77.72 · 2023: $252 · 2024: $145 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $589.88 | 2019-2025 | |
| Janssen Biotech, INC. | $97.98 | 2019-2024 | Tremfya |
| Genzyme Corporation | $96.66 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $84.55 | 2019-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $84.00 | 2019-2024 | |
| Allergan, INC. | $76.35 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $74.97 | 2023-2024 | Zoryve |
| Incyte Corporation | $44.32 | 2025 | Opzelura |
| Pfizer INC. | $43.18 | 2019-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $37.97 | 2023 | Valchlor |
| Ucb, INC. | $31.54 | 2021 | |
| Galderma Laboratories, L.P. | $31.19 | 2021-2025 | Aklief |
| Verrica Pharmaceuticals INC. | $24.62 | 2023 | Ycanth |
| Paratek Pharmaceuticals, INC. | $23.58 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.71 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $14.46 | 2019 | |
| Biocompatibles, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Minars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.